Company news
Biome Australia Ltd (ASX:BIO) news
Biome Australia Ltd news releases on 6ix. Latest, Sep 8, 2026: New Activated Probiotics launches for H1 FY27
Press releases & updates
New Activated Probiotics launches for H1 FY27
September 8, 2026
Biome to Launch in China
August 26, 2026
International Markets Presentation
July 26, 2026
FY26 Trading Update
June 30, 2026
Biome Signs Australian Manufacturing Agreement
June 2, 2026
BMB18 clinical trial expands to dual site
May 26, 2026
Probiotical Exclusive Supply Agreement Extended
May 11, 2026
Patent Application Filed for Probiotic Strain BMB18
April 26, 2026
Biome First Half FY26 Results and Highlights
February 22, 2026
Appendix 4D & Half Yearly Report
February 22, 2026
Ethics Approval Granted for BMB18 Human Clinical Trial
February 2, 2026
Biome secures distribution with Fullscript Canada
February 1, 2026
Quarterly Activities & Cashflow Report
January 26, 2026
Trading Update
January 4, 2026
Biome Launches Human Clinical Trial on BMB18
December 14, 2025
Q1 FY26 Revenue Guidance
September 2, 2025
Biome Secures New Zealand Pharmacy Deal
September 1, 2025
Biome Secures Distribution with Mecca and GoVita
August 27, 2025
Financial Year 2025 Preliminary Results
August 26, 2025
Preliminary Final Report
August 26, 2025
International Market Update and New Distribution Agreements
July 14, 2025
Response to ASX Cleansing Notice Timing Letter
July 9, 2025
Biome Achieves Record Sales Revenue
June 30, 2025
Biome Launches Activated Therapeutics Range
May 5, 2025
Activated Probiotics New Product Launches
April 29, 2025
Biome secures $5 million debt facilities with NAB
April 2, 2025
Biome reports strong sales revenue for Q3 FY25
April 1, 2025
Biome First Half FY25 Results and Highlights
February 17, 2025
Biome Secures FaBA Co-investment for IP Development
February 4, 2025
Positive Results on Clinical Development of BMB18
January 29, 2025
Biome Increases Australian Distribution
January 23, 2025
Biome reports record quarterly sales revenue for Q2 FY25
January 5, 2025
Q2 Revenue Guidance
November 26, 2024
Biome Strain Development Program Success
November 13, 2024
Business and International Market Update
November 12, 2024
Record quarterly sales revenue for Q1
September 30, 2024
Vision 27 Strategic Plan Presentation
September 29, 2024
Biome Commences Test Market In Canada
September 18, 2024
Q1 FY25 Revenue Guidance
September 2, 2024
Company Presentation
August 26, 2024
Amended Preliminary Financial Report
August 26, 2024
Financial Year 2024 Key Results
August 25, 2024
Clinically Proven Cholesterol Reducing Probiotic Launched
August 18, 2024
Biome shares three-year revenue target
July 28, 2024
Biome Achieves Record Sales Revenue in FY24
June 30, 2024
Biome expects to exceed FY24 forecast
June 11, 2024
International Market Update and Health Canada approvals
May 28, 2024
Non-Deal Investor Presentation April 2024
April 10, 2024
First Quarter of Positive Underlying Cash Flow
April 1, 2024
Biome Releases First Half FY2024 Results
February 21, 2024